Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis - Arun J. Sanyal; Philip N. Newsome; Iris Kliers; Laura Harms Østergaard; Michelle T. Long; Mette Skalshøi Kjær; Anna M.G. Cali; Elisabetta Bugianesi; Mary E. Rinella; Michael Roden; Vlad Ratziu (New England Journal of Medicine, 2025)